New
Start Free Trial
Pricing
Log In
Log In

Make better decisions, faster

Discover and act on private market activity with predictive company intelligence
Get the full experience.
See Plans

This month on Crunchbase

Unrivaled Logo
Unrivaled
Partnership Announcement
UNRIVALED ANNOUNCES MOUNT SINAI MEDICAL CENTER AS THE LEAGUE'S OFFICIAL MEDICAL PARTNER FOR THE 2026 SEASON
Anthropic Logo
Anthropic
IPO Prediction
It is very likely that Anthropic will IPO
Saviynt Logo
Saviynt
Growth Insight
Saviynt raised $700 million in a Series B growth equity round led by KKR, with participation from Sixth Street Growth, TenEleven, and Carrick Capital Partners, valuing the company at approximately $3 billion. This funding was aimed at supporting the company's growth in the identity security sector, particularly in response to rising demand for securing human and AI-driven identities. Additionally, Saviynt expanded its geographic presence by establishing a regional headquarters in Dubai to serve customers across the Middle East and North Africa region, and it opened new offices in Singapore, London, Poland, and India, enhancing its footprint in Asia Pacific, Europe, and the Middle East.
Learn about the companies that matter to you (for free)Get personalized private market analysis
Anthropic Logo
Anthropic
Funding Prediction
It is probable that Anthropic will raise funding
Function Health Logo
Function Health
Partnership Announcement
Function Launches Integration with Claude, Powered by Anthropic
xAI Logo
xAI
Funding Prediction
It is probable that xAI will raise funding
Google for Startups Logo
Google for Startups
Investor Insight
Google for Startups backs seed-stage AI and software companies, primarily via grants and non-equity support, with a geographic focus on European hubs including Ukraine, the United Kingdom, and Estonia.
European Investment Bank Logo
European Investment Bank
Growth Prediction
It is very likely that European Investment Bank will grow
Encoded Therapeutics Logo
Encoded Therapeutics
Award
Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome
OpenAI Logo
OpenAI
Growth Prediction
It is probable that OpenAI will grow
Anything Logo
Anything
Growth Insight
Anything acquired the premium domain name 'anything.com' for $2,000,000 to align its brand with its vision of enabling anyone to build and monetize software. The company saw over 30,000 new sign-ups within 72 hours of launching 'Anything', pushing total registered users past 500,000. Following the public debut of its AI coding agent, Anything's user base grew to over 700,000 registered users shortly after launch. The company raised $11,000,000 at a $100,000,000 valuation, bringing total funding to $19,500,000. Within two weeks of launching its AI business builder product, Anything reached an annualized revenue run rate of $2 million, indicating rapid revenue growth from the pivot.
OpenAI Logo
OpenAI
IPO Prediction
It is very likely that OpenAI will IPO
Learn about the companies that matter to you (for free)Get personalized private market analysis
Sohar Health Logo
Sohar Health
Partnership Announcement
Sohar Health and Tava Health Partnership Speeds Employee Access to Therapy
Perplexity Logo
Perplexity
Acquisition Prediction
It is probable that Perplexity will be acquired
Xiangjiang State Investment Logo
Xiangjiang State Investment
Investor Insight
Xiangjiang State Investment backs seed to Series B companies in manufacturing, software, and advanced materials, concentrating on Hunan and Fujian in China within the broader Asian region.
Perplexity Logo
Perplexity
Funding Prediction
It is probable that Perplexity will raise funding
SEI Logo
SEI
Leadership Hire
SEI Announces Leadership Transitions in Cincinnati Office
Perplexity Logo
Perplexity
IPO Prediction
It is probable that Perplexity will IPO
FibroBiologics Logo
FibroBiologics
Growth Insight
FibroBiologics reported a net loss of $15.4 million for the nine months ended September 30, 2025, compared to a net loss of $8.1 million for the same period in 2024, indicating an increase in losses year-over-year. For the six months ended June 30, 2025, the company reported a net loss of approximately $9.6 million, up from a net loss of approximately $7.6 million for the same period in 2024. The company expanded its research capacity in 2025 by recruiting additional scientific staff and opening a larger laboratory and manufacturing facility. FibroBiologics closed the third $5 million tranche of a $25 million total financing to support R&D and clinical trials. Additionally, the company raised approximately $4 million through a registered direct offering and concurrent private placement, with potential additional proceeds of about $4 million from unregistered warrants. Multiple registered direct offerings in late 2025 raised approximately $7.2 million in total to strengthen its balance sheet and eliminate outstanding debt.
Perplexity Logo
Perplexity
Growth Prediction
It is probable that Perplexity will grow
SolaREIT Logo
SolaREIT
Partnership Announcement
SolaREIT Expands Revolving Credit Facility to $80 Million with Atlantic Union Bank and EagleBank
Learn about the companies that matter to you (for free)Get personalized private market analysis
Polymarket Logo
Polymarket
Funding Prediction
It is probable that Polymarket will raise funding
Alpha Bank Logo
Alpha Bank
Investor Insight
Alpha Bank provides debt and post-IPO debt financing to manufacturing, transportation, and food and beverage companies, focusing on investments within Greece, particularly in Athens, Maroúli, and Sérres.
Polymarket Logo
Polymarket
Growth Prediction
It is very likely that Polymarket will grow
Trust & Will Logo
Trust & Will
Product Launch
Trust & Will Launches an Attorney Platform to Support the Next Generation of Estate Planning Attorneys
Polymarket Logo
Polymarket
Acquisition Prediction
It is probable that Polymarket will be acquired
Spinny Logo
Spinny
Growth Insight
Spinny reported FY25 revenue of INR 4,657 crore, reflecting a 25% year-over-year increase. The company also reduced its net loss by 28% YoY to INR 423.8 crore from INR 590.3 crore in the previous fiscal year. Additionally, revenue from the sale of cars on Spinny's platform increased 26% YoY to INR 45,533 crore in FY25 from INR 36,214 crore in FY24. The company expanded its car-selling services to 10 cities in Karnataka State, South India, increasing its geographic presence in the region. Spinny raised $170 million in June 2025, maintaining a valuation between $1.7 billion and $1.8 billion, and has raised a total of approximately $676 million to date.
Armis Logo
Armis
Growth Prediction
It is very likely that Armis will grow
Kipu Health Logo
Kipu Health
Product Launch
Kipu Introduces the First Intelligent Operating System for Behavioral Healthcare Industry
Harness Logo
Harness
IPO Prediction
It is probable that Harness will IPO
Learn about the companies that matter to you (for free)Get personalized private market analysis
Third Prime Logo
Third Prime
Investor Insight
Third Prime backs seed to early-stage software, AI, and financial services companies, primarily investing in New York and Los Angeles in the U.S., with additional activity in Seoul, South Korea.
Harness Logo
Harness
Growth Prediction
It is very likely that Harness will grow
Disc Medicine Logo
Disc Medicine
Award
Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
Harness Logo
Harness
Funding Prediction
It is probable that Harness will raise funding
Klaviyo Logo
Klaviyo
Growth Insight
Klaviyo reported a 32% year-over-year increase in revenue for Q3 FY25, reaching $310.9 million, and raised its full-year revenue guidance to between $1.215 billion and $1.219 billion, reflecting a 30% increase year-over-year. The company also noted a significant increase in its customer base, growing to over 183,000 as of September 30, 2025, up from over 157,000 the previous year. Additionally, Klaviyo's operating cash flow increased to $54.8 million in Q3 FY25 from $38.8 million in Q3 FY24, and free cash flow improved to $47.1 million from $34.2 million. The number of large customers generating over $50,000 in annual recurring revenue rose to 3,563, a 36% increase year-over-year. Klaviyo's revenue for 2022 was reported at $473 million, a 63% increase from $289 million in 2021.
Lovable Logo
Lovable
Growth Prediction
It is very likely that Lovable will grow
HIF Global Logo
HIF Global
Partnership Announcement
HIF Global and Antarctica21 Renew Exclusive Alliance, Expanding the Use of e-Fuels in Antarctic Travel
Lovable Logo
Lovable
Funding Prediction
It is probable that Lovable will raise funding
Viellard Migeon Et Compagnie Sa Logo
Viellard Migeon Et Compagnie Sa
Investor Insight
Viellard Migeon Et Compagnie Sa invests in post-IPO equity in sporting goods within the commerce, shopping, and sports sectors, with a geographical focus on Helsinki, Southern Finland, Finland, and broader Europe.
Learn about the companies that matter to you (for free)Get personalized private market analysis
Replit Logo
Replit
Funding Prediction
It is probable that Replit will raise funding
Asimov Logo
Asimov
Partnership Announcement
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
Octane Logo
Octane
Funding Prediction
It is probable that Octane will raise funding
Factorial Energy Logo
Factorial Energy
Growth Insight
Factorial Energy sold much of its Methuen plant battery-making equipment to Physical Sciences, enabling PSI to ramp lithium-ion production for defense uses as it took over the site. Factorial raised $100 million through a PIPE private placement of common stock in connection with its business combination with Cartesian Growth Corporation III, supporting commercialization of its solid-state battery technology. Factorial exited its Methuen, Massachusetts manufacturing facility, buying out its lease and ceasing operations at the site after investing over $24 million. Factorial merged with SPAC Cartesian Growth Corp. III in a deal that took the battery startup public at a valuation of $1.1 billion and raised about $100 million. Stellantis and Factorial were reported as continuing solid-state battery validation work targeting a demonstration fleet in 2026, highlighting ongoing R&D progress toward automotive deployment.
Octane Logo
Octane
Growth Prediction
It is very likely that Octane will grow
Truvian Sciences Logo
Truvian Sciences
Product Launch
Truvian Health Rapidly Expands TruVerus™ Menu with FDA Clearances for Cardiovascular, Liver, and Core Metabolic Health Tests
Octane Logo
Octane
IPO Prediction
It is probable that Octane will IPO
Delphi Ventures Logo
Delphi Ventures
Investor Insight
Delphi Ventures invests in pre-seed to Series A blockchain, cryptocurrency, and Web3 software companies, with activity across New York and Delaware in the US and Singapore in Asia.
Nothing Logo
Nothing
IPO Prediction
It is probable that Nothing will IPO
Learn about the companies that matter to you (for free)Get personalized private market analysis
CarMax Logo
CarMax
Leadership Hire
Why CarMax Stock Slipped 53% In 2025
Nothing Logo
Nothing
Growth Prediction
It is probable that Nothing will grow
Flock Safety Logo
Flock Safety
Growth Insight
Flock Safety acquired Lucidus Solutions, integrating its analytics and data fusion capabilities into its public safety platform. The company also acquired drone company Aerodome to support its automated security drone offering and Nashville-based AI search startup Lucidus in February to enhance its Nova search product. Flock Safety closed a $275 million funding round led by Andreessen Horowitz, raising its valuation to $7.5 billion to accelerate product innovation and expand manufacturing in Georgia. The company's revenue increased about 70% from an estimated $175 million in 2023, reflecting rapid growth in deployments.
Nothing Logo
Nothing
Funding Prediction
It is probable that Nothing will raise funding
SAGA Diagnostics Logo
SAGA Diagnostics
Product Launch
SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer
General Catalyst Logo
General Catalyst
Growth Prediction
It is very likely that General Catalyst will grow
Expeditions Logo
Expeditions
Investor Insight
Expeditions Fund backs pre-seed to Series A startups in information technology, software, and AI, investing primarily across the United Kingdom and Estonia in Europe.
Cyera Logo
Cyera
Growth Prediction
It is very likely that Cyera will grow
Kipu Health Logo
Kipu Health
Partnership Announcement
Kipu Introduces the First Intelligent Operating System for Behavioral Healthcare Industry
Learn about the companies that matter to you (for free)Get personalized private market analysis
Cyera Logo
Cyera
IPO Prediction
It is probable that Cyera will IPO
Myome Logo
Myome
Growth Insight
Illumina made a strategic investment in MyOme to support its Proactive Health clinical trial and product expansion. This investment was part of a collaboration that included continued financing support from Natera, Sequoia Capital, and the Duquesne Family Office. MyOme initiated the Proactive Health (MPH) Trial, which is a prospective clinical study utilizing whole-genome sequencing and AI-driven risk prediction models.
Zepto Logo
Zepto
Funding Prediction
It is probable that Zepto will raise funding
Exl Logo
Exl
Award
EXL named a Leader in five quadrants in ISG Provider Lens™ Insurance Services Global Report
Zepto Logo
Zepto
IPO Prediction
It is probable that Zepto will IPO
Rock Yard Ventures Logo
Rock Yard Ventures
Investor Insight
Rock Yard Ventures invests in seed-stage software, AI, and information technology companies, mainly in San Francisco and New York within the United States.
Suno Logo
Suno
Funding Prediction
It is probable that Suno will raise funding
Anumana Logo
Anumana
Leadership Hire
Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors
Suno Logo
Suno
Growth Prediction
It is probable that Suno will grow
Learn about the companies that matter to you (for free)Get personalized private market analysis
Galderma Logo
Galderma
Growth Insight
Galderma reported record net sales of 3.737 billion USD for the first nine months of 2025, which represented a 15.0% year-on-year increase at constant currency compared to 3.259 billion USD in the same period of 2024. For the first half of 2025, Galderma achieved net sales of 2.448 billion USD, reflecting a 12.2% year-on-year growth at constant currency. The company also reported a 21% increase in Q3 2025 net sales, reaching 1.289 billion USD, driven by strong performance in Injectable Aesthetics and the Nemluvio dermatology portfolio. Additionally, Galderma's Therapeutic Dermatology net sales for H1 2025 were 489 million USD, up 26.9% year-on-year at constant currency, while its Injectable Aesthetics net sales were 1.24 billion USD, up 9.8% year-on-year at constant currency. The company raised its full-year net sales guidance to 12%-14% growth, up from the previous target of 10%-12%.
Suno Logo
Suno
Acquisition Prediction
It is probable that Suno will be acquired
Duetti Logo
Duetti
Partnership Announcement
Introducing: Duetti and Billboard’s Music Finance Index
HSG Logo
HSG
Growth Prediction
It is very likely that HSG will grow
BdsVC Logo
BdsVC
Investor Insight
BdsVC invests in seed and early-stage AI, machine learning, and IT software and data companies, with a geographic focus spanning the United States, Mexico, and India.
European Bank for Reconstruction and Development Logo
European Bank for Reconstruction and Development
Growth Prediction
It is probable that European Bank for Reconstruction and Development will grow
Duetti Logo
Duetti
Product Launch
Introducing: Duetti and Billboard’s Music Finance Index
Quantum Systems Logo
Quantum Systems
IPO Prediction
It is probable that Quantum Systems will IPO
IonQ Logo
IonQ
Growth Insight
IonQ completed several significant acquisitions, including Oxford Ionics for approximately $1.08 billion, marking the largest acquisition in quantum computing history. This acquisition aimed to enhance IonQ's trapped-ion technology and expand its capabilities in quantum computing. Additionally, IonQ acquired Capella Space to integrate satellite capabilities into its quantum technology, further advancing its vision for a space-based quantum key distribution network. The company also completed the acquisition of Lightsynq, enhancing its quantum networking technology. IonQ's revenue for Q3 2025 reached $39.9 million, representing a 222% year-over-year increase, driven by strong demand for its quantum computing services. Furthermore, IonQ raised $1 billion through an equity offering to support its growth and expansion plans, boosting its cash reserves significantly. Despite a net loss of $1.3 billion for the first three quarters of 2025, the company demonstrated strong revenue growth and strategic acquisitions that positioned it favorably within the quantum computing sector.
Learn about the companies that matter to you (for free)Get personalized private market analysis
Temasek Holdings Logo
Temasek Holdings
Growth Prediction
It is very likely that Temasek Holdings will grow
Kyber Logo
Kyber
Product Launch
Aspire General Automates 44% of Claims Correspondence in 90 Days With Kyber
Stonepeak Logo
Stonepeak
IPO Prediction
It is probable that Stonepeak will IPO
Outlier Ventures Logo
Outlier Ventures
Investor Insight
Outlier Ventures invests at pre-seed, seed, and early stage in blockchain, Web3, AI, and software-focused financial services, with activity across Europe, Asia, and North America, including London, Singapore, and Atlanta.
Stonepeak Logo
Stonepeak
Growth Prediction
It is very likely that Stonepeak will grow
Nationwide Logo
Nationwide
Product Launch
Nationwide Launches New ‘Call Checker’ as Brits Lose Confidence Due to Scam Calls
Harvey Logo
Harvey
Funding Prediction
It is probable that Harvey will raise funding
Heirs Energies Logo
Heirs Energies
Growth Insight
Heirs Energies acquired a 20.07% equity stake in Seplat Energy, purchasing 120.4 million shares for approximately $500 million. This acquisition made Heirs Energies the largest shareholder in Seplat Energy, strengthening indigenous ownership of Nigerian energy assets. Additionally, Heirs Energies secured a $750 million loan from African Export-Import Bank to finance the expansion of an existing oil field, supporting its broader growth strategy in Nigeria's hydrocarbon sector.
Glean Logo
Glean
Funding Prediction
It is probable that Glean will raise funding
Learn about the companies that matter to you (for free)Get personalized private market analysis
Wex Logo
Wex
Leadership Hire
WEX Advances Multi-Year Board Refreshment Plan
Function Health Logo
Function Health
Growth Prediction
It is probable that Function Health will grow
Delta40 Logo
Delta40
Investor Insight
Delta40 invests in seed-stage ventures in agriculture, energy, and solar, focusing on sustainability across Nairobi (Kenya), Lagos (Nigeria), and Kampala (Uganda) in Africa.
Function Health Logo
Function Health
Funding Prediction
It is probable that Function Health will raise funding
CRISPR Therapeutics Logo
CRISPR Therapeutics
Partnership Announcement
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones
Glean Logo
Glean
Growth Prediction
It is very likely that Glean will grow
Zeta Global Logo
Zeta Global
Growth Insight
Zeta Global completed the acquisition of Marigold’s enterprise software business, including brands like Marigold Loyalty, Cheetah Digital, Selligent, Sailthru, Liveclicker, and Grow, for up to $325 million in cash, stock, and seller notes. In Q2 2025, Zeta Global generated $42 million in operating cash flow and $34 million in free cash flow, reflecting strong financial performance. The company reported Q2 2025 revenue of $308.4 million, up from $227.8 million in Q2 2024, representing a 35% year-over-year increase. Zeta Global's free cash flow for the first half of 2025 increased to $61.8 million from $34.9 million in the first half of 2024. The customer count increased by more than 20%, and Zeta added 5 net new scaled customers in Q3, bringing total scaled customers to 572. Adjusted EPS for Q3 2025 increased to $0.20, beating the consensus estimate. Zeta Global's net income margin improved from approximately -40% to -4% over the past three years, indicating progress toward profitability.
Glean Logo
Glean
IPO Prediction
It is probable that Glean will IPO
Clinical Ink Logo
Clinical Ink
Product Launch
Clinical ink Announces SPUR™ Adherence Solution for Cardiometabolic Disease Management in the US
Anysphere Logo
Anysphere
IPO Prediction
It is probable that Anysphere will IPO
54Co Logo
54Co
Investor Insight
54Co invests in seed-stage companies in agriculture, service, and supply chain sectors, with a focus on Nairobi and broader Kenya and African markets.
Harvey Logo
Harvey
IPO Prediction
It is probable that Harvey will IPO
Apptegy Logo
Apptegy
Product Launch
Apptegy Announces Community Experience: An AI-Powered Inbound Communication Hub Built for K-12
Harvey Logo
Harvey
Growth Prediction
It is very likely that Harvey will grow
Profusa Logo
Profusa
Growth Insight
Profusa expanded its European customer base by adding vascular surgeon Prof. Yann Gouëffic as a customer to adopt the Lumee oxygen monitoring system in practice and clinical studies; his affiliated network handles approximately 8% of CLTI cases in France. Profusa reported continued growth of its European customer base, adding the Department of Vascular Surgery at AZ Sint-Blasius Hospital, Belgium. Profusa secured a $100 million equity line of credit from Ascent Partners to support product innovation, scaling operations, and its real-time biosensing healthcare strategy. Profusa raised $12 million in gross proceeds from a convertible PIPE note and $7 million from an equity line of credit following its merger with NorthView Acquisition Corporation to strengthen its balance sheet and fund near-term growth. Profusa completed a reverse recapitalization merger with NorthView Acquisition Corporation, valuing Profusa equity at $155 million and resulting in Profusa trading on Nasdaq as PFSA. Profusa achieved a key R&D milestone with pilot phase results from a U.S. FDA-advised study showing its Lumee implantable oxygen sensor safely and effectively monitors tissue oxygen in PAD patients over one year, meeting primary endpoints and correlating with tcpO2.
Anysphere Logo
Anysphere
Growth Prediction
It is very likely that Anysphere will grow
Browse By: Organizations, People, Events
Stay Connected
  • Crunchbase Blog
  • Crunchbase News
  • Subscribe to the Crunchbase Daily
Who We Are
  • Company
  • Careers
  • Partners
  • Press
  • Contact Us
What We Do
  • Crunchbase Pro
  • Crunchbase Business
  • Marketplace
  • Data Licensing
  • Customer Stories
  • Pricing
Helpful Links
  • Create Profile
  • Featured Lists and Searches
  • Knowledge Center
  • Privacy
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d16d5d2 1)
|